Br J Ophthalmol 1999;83:688-691 ( June )
Ocular signs and symptoms and vitamin A status in patients with
cystic fibrosis treated with daily vitamin A supplements
Ejaz A Ansaria, Kamal Sahnia, Christine Etheringtonb, Alison Mortonb, Steven P Conwayb, Eduardo Moyab, James M Littlewoodb
a Department of
Ophthalmology, St James's and Seacroft University Hospitals,
Leeds LS14 6UH, b Regional Paediatric and Adult Cystic Fibrosis
Unit at St James's and Seacroft University Hospitals, Leeds
LS14 6UH
Correspondence to: Mr E A Ansari, Department of Ophthalmology, Ward A4, Cardiff Eye Unit,
University Hospital of Wales, Cardiff CF4 4XW.
Accepted for publication 10 December 1998
BACKGROUND/AIMS
Patients
with cystic fibrosis (CF) may have low plasma vitamin A levels from
malabsorption, zinc deficiency, liver disease, or poor compliance with
prescribed supplements. In view of the increasing number of adults with
CF, many of whom drive cars, it is important to assess vitamin A
status. In our centre an attempt has been made to achieve normal levels
of fat soluble vitamins by annual estimation of plasma levels and
appropriate oral supplementation. This study aimed to determine if this
approach prevents vitamin A deficiency and the consequent problems with
dark adaptation.
METHODS
The study was
conducted at the regional adult and paediatric cystic fibrosis unit and
the patients were recruited from there. Dark adaptation studies were
conducted at the department of ophthalmology, St James's University
Hospital. All patients are regularly seen in the outpatient department
by a CF specialist dietitian and have a comprehensive annual dietary
assessment. 28 patients had the following investigations: serum
retinol, plasma zinc, serum retinol binding protein, liver function
tests, dark adaptation, contrast sensitivity, and anterior ocular
surface status. 25 age and sex matched controls without CF or ocular
pathology were also recruited for the dark adaptation study.
RESULTS
None of the
patients had vitamin A deficiency, the median value of serum retinol
being 48 µg/dl, range 31-80 µg/dl (normal range 30-80 µg/dl).
Dark adaptation was normal in all cases compared with the control group
where the mean value was 3.4 log units of threshold luminance (95%
confidence interval 2.4-4.0). None of the test group had a value of
threshold luminance 2 SD above the mean value for the control group.
Eight patients had reduced contrast sensitivity. The median value for
serum zinc was 14.2 µmol/ l, range 13-81 µmol/l (normal range
8-23 µmol/l) and the median value for retinol binding protein was 36 mg/l, range 13-81 mg/l (normal range 35-58 mg/l). There was no
correlation between dark adaptation and serum retinol, zinc, or retinol
binding protein. Two patients had clinical evidence of dry eye.
CONCLUSION
Regular
estimates of plasma vitamin A together with appropriate supplementation
and expert dietetic review can maintain normal dark adaptation in
patients with cystic fibrosis. The occurrence of reduced contrast
sensitivity function is well documented but remains an unexplained
phenomenon and deserves further study.
© 1999 by British Journal of Ophthalmology